The KMT2A recombinome of acute leukemias in 2023
Claus Meyer(Goethe University Frankfurt), Emmanuelle Clappier(Centre National de la Recherche Scientifique), Pablo Menéndez(Parque Tecnológico de la Salud), Éric Delabesse(Hôpital Necker-Enfants Malades), Maria Luiza Macedo Silva(Instituto Nacional de Câncer - INCA), L Corral Abascal(University of Milano-Bicocca), Mariana Emerenciano(Instituto Nacional de Câncer - INCA), Susanne Kubetzko(University Children's Hospital Zurich), Simon Bomken(Clinical Research Institute), Jan Trka(Charles University), T Lund-Aho(Fimlab (Finland)), Shai Izraeli(Tel Aviv University), Maria S. Pombo‐de‐Oliveira(Instituto Nacional de Câncer - INCA), Vincent H. J. van der Velden(Erasmus MC), Thomas Burmeister(Sana Klinikum Lichtenberg), Mirkka Montonen(University of Turku), K. Katsibardi(National and Kapodistrian University of Athens), Luca Lo Nigro(Policlinico Universitario di Catania), Bruno A. Lopes(Goethe University Frankfurt), Nathalie Grardel(Inserm), Paula Gameiro(IPO Porto), Victoria Malina -Marcu(Sheba Medical Center), Rathana Kim(Centre National de la Recherche Scientifique), Edwin Sonneveld(Princess Máxima Center), Beat W. Schäfer(University Children's Hospital Zurich), Udo zur Stadt(Universität Hamburg), Tuija Lundán(University of Turku), Hélène Lapillonne(Sorbonne Université), Paola Ballerini(Sorbonne Université), Clara Bueno(Institució Catalana de Recerca i Estudis Avançats), Daniela Gröger(Humboldt-Universität zu Berlin), Łukasz Sędek(Medical University of Silesia), Patrizia Larghero(Goethe University Frankfurt), Nicola C. Venn(Children's Cancer Institute Australia), R. Price(Birmingham Women’s and Children’s NHS Foundation Trust), Vesa Juvonen(University of Turku), Tomasz Szczepański(Medical University of Silesia), Maria Keernik(Tartu University Hospital), Л. Г. Фечина(Institute of Medical Cell Technologies), Giovanni Cazzaniga(University of Milano-Bicocca), Rosemary Sutton(UNSW Sydney), Keren Shichrur(Schneider Children's Medical Center), Roberto R. Capela de Matos(Instituto Nacional de Câncer - INCA), Grigory Tsaur(Institute of Medical Cell Technologies), Jan Zuna(Charles University), Cornelia Eckert(Humboldt-Universität zu Berlin), Julia Mason(Birmingham Women’s and Children’s NHS Foundation Trust), J. Kim(Goethe University Frankfurt), H O Madsen(Copenhagen University Hospital), Audrey Bidet(Centre Hospitalier Universitaire de Bordeaux)
Cited by 214
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k